These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3054910)
1. Nerve sparing retroperitoneal lymphadenectomy in clinical stage I, low stage II and after chemotherapy in stage III nonseminomatous testicular cancer. Javadpour N Prog Clin Biol Res; 1988; 277():53-62. PubMed ID: 3054910 [TBL] [Abstract][Full Text] [Related]
2. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L; J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815 [TBL] [Abstract][Full Text] [Related]
3. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements. Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394 [TBL] [Abstract][Full Text] [Related]